ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $27,840,842 | +92885.7% | 4,468,835 | 0.0% | 18.82% | -5.5% |
| Q3 2022 | $29,941 | +5.3% | 4,468,835 | 0.0% | 19.92% | +41.7% |
| Q2 2022 | $28,421 | +37.1% | 4,468,835 | 0.0% | 14.05% | +62.5% |
| Q1 2022 | $20,735 | -7.2% | 4,468,835 | 0.0% | 8.65% | -14.3% |
| Q4 2021 | $22,344 | -34.2% | 4,468,835 | +58.5% | 10.09% | -13.5% |
| Q3 2021 | $33,967 | -43.0% | 2,818,835 | 0.0% | 11.67% | -44.7% |
| Q2 2021 | $59,618 | -20.7% | 2,818,835 | +5.2% | 21.09% | -0.1% |
| Q1 2021 | $75,169 | +7.9% | 2,679,835 | 0.0% | 21.12% | +8.9% |
| Q4 2020 | $69,675 | -30.1% | 2,679,835 | 0.0% | 19.39% | -13.1% |
| Q3 2020 | $99,609 | -27.6% | 2,679,835 | 0.0% | 22.32% | -22.6% |
| Q2 2020 | $137,502 | +101.8% | 2,679,835 | 0.0% | 28.84% | +22.9% |
| Q1 2020 | $68,144 | -43.5% | 2,679,835 | 0.0% | 23.47% | -31.8% |
| Q4 2019 | $120,615 | +22.8% | 2,679,835 | 0.0% | 34.40% | +43.8% |
| Q3 2019 | $98,242 | -21.2% | 2,679,835 | 0.0% | 23.93% | -4.6% |
| Q2 2019 | $124,665 | +15.9% | 2,679,835 | 0.0% | 25.08% | +24.3% |
| Q1 2019 | $107,595 | -12.7% | 2,679,835 | 0.0% | 20.17% | -20.5% |
| Q4 2018 | $123,272 | +5.6% | 2,679,835 | +1.9% | 25.39% | +1.2% |
| Q3 2018 | $116,685 | +13.2% | 2,629,835 | 0.0% | 25.08% | +24.6% |
| Q2 2018 | $103,063 | -45.0% | 2,629,835 | +1.6% | 20.13% | -31.7% |
| Q1 2018 | $187,279 | +22.5% | 2,589,235 | +11.5% | 29.46% | +49.6% |
| Q4 2017 | $152,935 | +33.0% | 2,322,835 | +1.2% | 19.68% | +12.7% |
| Q3 2017 | $115,022 | +339.1% | 2,294,935 | +305.5% | 17.46% | +343.1% |
| Q2 2017 | $26,194 | – | 566,000 | – | 3.94% | – |
Download | ||||||